Teresa Reguly > Torys > Toronto, Canada > Lawyer Profile
79 WELLINGTON STREET WEST, SUITE 3000
BOX 270, TD CENTRE
- Go to...
Teresa’s scientific fluency supports her broad intellectual property skills and business-minded approach, helping clients realize and manage their intellectual property and product regulatory strategy.
Teresa provides ongoing advice to clients who sell regulated products in the food, pharmaceutical, biotechnology and medical device industries.
She advises on intellectual property and regulatory issues in the chemical, biochemical and pharmaceutical fields, including the validity patentability and infringement of intellectual property rights. Teresa has extensive experience with drafting, filing and prosecuting patent applications and is frequently involved in drafting and negotiating IP licensing, research and development, co-promotion, marketing and confidentiality agreements for her clients.
She also provides guidance on Food and Drugs Act compliance, establishment licensing, product licensing, packaging and labeling, drug pricing and formulary listings. She has deep knowledge in the advertising and promotion of consumer products, food and health products, as well as mandatory reporting and corrective actions.
Her work regularly includes advising clients across industries on privacy issues, cross-border transfer of personal information and compliance with privacy law obligations, particularly involving personal health information.
Teresa is a registered patent agent in Canada. In September 2009, she was awarded for having achieved the highest overall mark in Canada on the 2008 patent agent exams.
Ontario Bar, 2007
Teresa worked with the LSUC on an e-Course titled “Privacy Law Basic for Business Lawyers,” which explains the privacy law obligations of a corporation in three situations: on an ongoing basis, in the course of a transaction and upon a privacy breach. It provides a foundation in privacy law for business lawyers of all experience levels.
Teresa is a member of the Toronto Intellectual Property Group, the Intellectual Property Institute of Canada (and of the IPIC Licensing Committee), Intellectual Property Owners Association (IPO) and the American Intellectual Property Law Association. She is also a member of the Food and Drug Law Institute (FDLI) and is a frequent presenter at these events.
Before joining Torys, Teresa was a research associate at the Samuel Lunenfeld Research Institute in Toronto.
Torys draws on 16 years of experience working with the cannabis industry, providing advice to banks, pension funds and blue-chip companies, as well as advising licensed producers. It offers significant M&A and capital markets expertise, advising on multiple consolidating acquisitions, IPOs and follow-on offerings. Much of this is thanks to the firm’s full-service New York office, which offers high-end cross-border advice. It also has a key focus on medical cannabis, where it covers both regulatory and transactional matters. Eileen McMahon and Cheryl Reicin jointly lead the team from Toronto, focusing on transactional and cannabis-related pharmaceutical issues, respectively. Teresa Reguly is also noteworthy for her IP, advertising and marketing work on behalf of cannabis growers, and Frazer House is known for his corporate law work.
The Toronto-based IP team at Torys concentrates on lifecycle management for its clients products, providing guidance on potential loss of market exclusivity and responding to IP disputes. One standout recent matter saw IP group chair Eileen McMahon and head of IP litigation Andrew Shaughnessy acting for Horizon Therapeutics in proceedings before the Patented Medicine Prices Review Board concerning allegations of excessive pricing. Andrew Bernstein has extensive litigation experience across all facets of IP, while on the transactional side, coordinator of the group, Edward Fan, is the key contact, honing his focus on the acquisition, exploitation and enforcement of IP. Teresa Reguly is particularly formidable in the biotechnology and medical device industries, and from a strong all-women pool of junior lawyers, counsels Nicole Mantini and Yolande Dufresne are particularly integral to the practice; the former due to her prominent reputation among North American and international pharmaceutical companies and the latter owing to her risk management and regulatory capabilities..
- Next Generation Partners - Canada > Intellectual property
- Cannabis - Canada
- Intellectual property - Canada
Top Tier Firm Rankings
- Capital markets
- Corporate and M&A
- Infrastructure projects
- Energy and natural resources > Oil and gas
- Energy and natural resources > Power
- Banking and finance
- Competition and antitrust
- Intellectual property
- Real estate and construction
- Restructuring and insolvency
- Indigenous law
- International expertise
- Energy and natural resources > Mining
- Public procurement
- International trade
- Labour and employment
- Dispute resolution